Bellevue Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-29
Closed -$2K 633
2021
Q1
$2K Sell
29
-50
-63% -$3.64K ﹤0.01% 591
2020
Q4
$5K Buy
79
+29
+58% +$1.89K ﹤0.01% 429
2020
Q3
$4K Hold
50
﹤0.01% 434
2020
Q2
$3K Hold
50
﹤0.01% 490
2020
Q1
$4K Buy
50
+2
+4% +$117 ﹤0.01% 419
2019
Q4
$4K Buy
+48
New +$4.2K ﹤0.01% 369

Other funds holding NGVT

Bellevue Asset Management's NGVT Position: Q2 2021 in Review

Bellevue Asset Management sold out of Ingevity (NGVT) in Q2 2021, closing a stake of 29 shares — an estimated $2K sold.

Bellevue Asset Management first reported a position in NGVT in Q4 2019 and held it in 6 quarters. The position peaked at $5K in Q4 2020. 277 funds tracked by Wall St. Rank hold NGVT as of Q2 2021.

  • Bellevue Asset Management reported no remaining Ingevity position as of Q2 2021 after selling out during the quarter.
  • Bellevue Asset Management sold 29 Ingevity shares in Q2 2021, an estimated $2K.
  • Bellevue Asset Management first reported a position in Ingevity in Q4 2019 and held it in 6 quarters.
  • Bellevue Asset Management's Ingevity position peaked at $5K in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Ingevity as of Q2 2021.

Based on Bellevue Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.